SCHEMBL2400567

SCHEMBL2400567

CCCCCCCCCCCO[PH](=O)Oc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.49
MLNR O43193 1/20 0.43
NR1I2 O75469 1/20 0.43
ESR1 P03372 1/20 0.43
NR3C1 P04150 1/20 0.43
PGR P06401 1/20 0.43
ADRB2 P07550 1/20 0.43
CHRM2 P08172 1/20 0.43
ADRB1 P08588 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CHRM1 P11229 1/20 0.43
DRD2 P14416 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
CHRM3 P20309 1/20 0.43
MAOA P21397 1/20 0.43
CNR1 P21554 1/20 0.43
SLC6A2 P23975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9602743 1.00 LTA4H (0.49) LTA4HMLNRNR1I2ESR1NR3C1
SCHEMBL27777417 1.00 LTA4H (0.49) LTA4HMLNRNR1I2ESR1NR3C1
SCHEMBL8420381 1.00 LTA4H (0.49) LTA4HMLNRNR1I2ESR1NR3C1
SCHEMBL9603013 1.00 LTA4H (0.49) LTA4HMLNRNR1I2ESR1NR3C1
SCHEMBL4912101 1.00 LTA4H (0.49) LTA4HMLNRNR1I2ESR1NR3C1
SCHEMBL23212140 1.00 LTA4H (0.49) LTA4HMLNRNR1I2ESR1NR3C1
Ammonia Solution, Strong SCHEMBL11316007 0.98 LTA4H (0.47) LTA4HMLNRNR1I2ESR1NR3C1
SCHEMBL3820583 0.98 LTA4H (0.50) LTA4HMLNRNR1I2ESR1NR3C1
Hexane SCHEMBL11818647 0.95 LTA4H (0.50) LTA4HMLNRNR1I2ESR1NR3C1
SCHEMBL9550970 0.93 LTA4H (0.50) LTA4HMLNRNR1I2ESR1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110295029-A1 NANOPARTICLE DISPERSIONS WITH LOW AGGREGATION LEVELS LUCENT TECHNOLOGIES, INC. (US) 2011-12-01 US disclosed
US-8012564-B2 Nanoparticle dispersions with low aggregation levels ALCATEL LUCENT (FR) 2011-09-06 US disclosed
US-20080017848-A1 NANOPARTICLE DISPERSIONS WITH LOW AGGREGATION LEVELS LUCENT TECHNOLOGIES (US) 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295029-A1 NANOPARTICLE DISPERSIONS WITH LOW AGGREGATION LEVELS CCNO, FLOT1, TSPO LTA4H 3050/4885MLNR 2858/4885NR1I2 4499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.